KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Newell Brands (NWL) Asset Writedowns and Impairment (2017 - 2025)

Newell Brands (NWL) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with $346.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $346.0 million, compared with a TTM value of $680.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $346.0 million, down 1.98% over the prior year.
  • Asset Writedowns and Impairment was $346.0 million for Q4 2025 at Newell Brands, up from $260.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $346.0 million in Q4 2025 and bottomed at $6.0 million in Q2 2024.
  • Average Asset Writedowns and Impairment over 5 years is $184.6 million, with a median of $204.0 million recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment soared 443.33% in 2022, then crashed 79.14% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $60.0 million in 2021, then skyrocketed by 443.33% to $326.0 million in 2022, then plummeted by 79.14% to $68.0 million in 2023, then surged by 282.35% to $260.0 million in 2024, then skyrocketed by 33.08% to $346.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for NWL at $346.0 million in Q4 2025, $260.0 million in Q3 2024, and $6.0 million in Q2 2024.